Michael Scolaro

Michael Scolaro

Sep 08, 2017

Group 6 Copy 169
-1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can we Measure the Body's Response to Implants by Testing the Blood?

Would you or a loved one someday benefit from a life-saving medical implant? However, the organisms adapt...

Giving Children a Better Life: Understanding Developmental Coordination Disorder

When I was young, I had developmental coordination disorder (DCD). I just didn’t know what it was. Children...

Backer Badge Funded